Batch-specific third-party analytical reports for JMC Peptides research materials.
Match the batch or lot number on the vial to the batch shown below before relying on a report. Each certificate relates only to the identified sample and batch.
How to use this library
Check the product name and batch number first, then open the matching PDF. The reports below are supplier-provided third-party analytical reports and are published as supplied. JMC Peptides intends to commission independent batch testing in future.
Published batch reports
BPC-157 — 10mg — Batch 26149
Reported purity: 99.66%
Report number: 1812445
Reported: 28 July 2026
TB-500 — 10mg — Batch 26147
Reported purity: 99.85%
Report number: 1812443
Reported: 26 July 2026
GHK-Cu — 100mg — Batch 26155
Reported purity: 99.64%
Report number: 1812451
Reported: 3 August 2026
NAD+ — 500mg — Batch 26152
Reported purity: 99.78%
Report number: 1812448
Reported: 31 July 2026
MOTS-C — 40mg — Batch 26158
Reported purity: 99.79%
Report number: 1812454
Reported: 6 August 2026
Tesamorelin — 10mg — Batch 26094
Reported purity: 99.66%
Report number: 1812390
Reported: 14 August 2026
KPV — 10mg — Batch 26088
Reported purity: 99.74%
Report number: 1812384
Reported: 8 August 2026
MT2 / Melanotan II — 10mg — Batch 26087
Reported purity: 99.64%
Report number: 1812383
Reported: 7 August 2026
Research-use notice
Certificates of Analysis are analytical references for the identified material and batch. They are not clinical evidence and do not establish suitability for human or veterinary use. JMC Peptides materials are supplied exclusively for laboratory research and analytical purposes.
